Hepatitis delta virus proteins repress hepatitis B virus enhancers and activate the alpha/beta interferon-inducible MxA gene
Virginie Williams(Inserm), Emmanuel Gordien(Inserm), Nadjia Radjef(Université Sorbonne Paris Nord), Paul Dény(Centre National de la Recherche Scientifique), Anne Goffard(Centre National de la Recherche Scientifique), Didier Hober(Centre Hospitalier Universitaire de Lille), Pierre Lebon(Université Paris Cité), Dina Kremsdorf(Inserm), Rémi Fagard(Université Sorbonne Paris Nord), Ségolène Brichler(Inserm)
Cited by 100
Related Papers
TLR3 Deficiency in Patients with Herpes Simplex Encephalitis
|Science|2007|1.1k
Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutières syndrome and mimic congenital viral brain infection
|Nature Genetics|2006|673
Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial
|The Lancet. Gastroenterology & hepatology|2017|249
Efficacy of peginterferon alpha-2b in chronic hepatitis delta: Relevance of quantitative RT-PCR for follow-up
|Hepatology|2006|238
Intrathecal synthesis of interferon-alpha in infants with progressive familial encephalopathy
|Journal of the Neurological Sciences|1988|228